NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation-Reference-Cited by-同舟云学术

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation

Published:2010-07 Issue:7 Volume:16 Page:871-890
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pavletic Steven Z.,Kumar Shaji,Mohty Mohamad,de Lima Marcos,Foran James M.,Pasquini Marcelo,Zhang Mei-Jie,Giralt Sergio,Bishop Michael R.,Weisdorf Daniel

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference244 articles.

1. Graft-versus-leukemia reactions after bone marrow transplantation;Horowitz;Blood,1990

2. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation;Ringden;Blood,2009

4. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse;Lee;Blood,2002

5. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation;Weiden;N Engl J Med,1981

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation;Nature Biotechnology;2024-08-21

2. Double-negative T cells utilize a TNFα–JAK1–ICAM-1 cytotoxic axis against acute myeloid leukemia;Blood Advances;2024-06-12

3. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies;Bone Marrow Transplantation;2024-05-23

4. Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2023-09

5. Acute Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The Good, the Bad, and the Ugly of Isolated Extramedullary Relapse in a Latin American Population;Transplantation and Cellular Therapy;2023-08